AFP and hepatocellular carcinoma: The most utilized pathological biomarker for HCC screening is alpha-fetoprotein (AFP) [27] which has several limitations, such as having high levels in liver cirrhosis and hepatitis, low sensitivity, and poor selectivity at an early stage of disease [28,29].